YC S21
Kiwi Biosciences
Patent-pending enzymes to break down common dietary triggers
About
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
Founders
- Anjie Liu
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Kiwi Biosciences.
See family office activityIndustry & Focus
HealthcareConsumer Health and WellnessBiotechFood Tech